{
  "contract_version": "supplier-contract-v0.1",
  "project": "per-901831",
  "supplier_group_id": "BECTON_DICKINSON_IND_CIRURGICAS_LTDA",
  "generated_at": "2026-04-17T01:52:48.126Z",
  "model": "gpt-4.1-mini",
  "provider_stack": [
    "openai"
  ],
  "narratives": {
    "positioning_summary": "该供应商为墨西哥注册的区域分销商，在 2010 年单一数据期内占据 3.77% 市场份额，处于市场稳定期。",
    "buyer_strategy": "其海外买家结构高度集中，Top1 买家 LABORATORIOS AC FARMA SA 占比 49.5%，对替代者而言攻坚难度极大，需优先攻克中小买家。",
    "pricing_read": "其加权均价为$0.0431/unit，比市场均价$0.0335/unit 高出 28.7%，主战场在$0.1841–$0.4536 价格带，从$0.0050–$0.0123 低价带切入最有机会。",
    "trend_read": "该供应商末年出货额与峰值持平，无新增或流失海外买家，整体处于维持现状而非扩张或退场阶段。",
    "competitive_angles": {
      "strengths": [
        "Top1 买家 LABORATORIOS AC FARMA SA 占比 49.5%，客户粘性高",
        "出货批次达 35 批，供应链稳定性强",
        "在$0.1841–$0.4536 价格带占据 32.9% 份额"
      ],
      "weaknesses": [
        "均价$0.0431/unit 比市场均价$0.0335/unit 高 28.7%",
        "Top1 买家依赖度 49.5%，其余买家体量小",
        "无付款记录，资金灵活性可能不足"
      ],
      "how_to_attack": "优先接触占比 9.6% 的 C^E LABDEALERS SA 和占比 6.4% 的 ALBIS SA 等中小买家。报价切入$0.0050–$0.0123 低价带，利用其均价高 28.7% 的劣势。利用其无付款记录，提供优于$0.0431/unit 的 FOB 价格并争取更灵活交付。"
    },
    "buyer_opportunities": [
      {
        "buyer": "C^E LABDEALERS SA (LABDEALERS SA)",
        "angle": "Top 依赖",
        "action": "本周联系该买家，报价$0.0050–$0.0123，强调比其当前均价$0.0431/unit 低 28.7% 的成本优势。"
      },
      {
        "buyer": "ALBIS SA",
        "angle": "Top 依赖",
        "action": "本周联系该买家，报价$0.0050–$0.0123，利用其仅占供应商 6.4% 份额的松动空间切入。"
      },
      {
        "buyer": "MEDIFARMA SA",
        "angle": "Top 依赖",
        "action": "本周联系该买家，报价$0.0050–$0.0123，针对其仅 2 批出货的弱依赖关系进行替换。"
      },
      {
        "buyer": "BECTON DICKINSON DEL URUGUAY SA SUC PERU",
        "angle": "Top 依赖",
        "action": "本周联系该买家，报价$0.0050–$0.0123，利用其仅 2.9% 的低占比快速建立合作。"
      },
      {
        "buyer": "PERUFARMA SA",
        "angle": "Top 依赖",
        "action": "本周联系该买家，报价$0.0050–$0.0123，尽管其占比 25.7%，但低价策略可逐步渗透。"
      }
    ]
  }
}